Philips launches IntelliSpace Cognition product in the U.S.
Royal Philips announced the U.S. debut of its new cognitive assessment platform IntelliSpace Cognition. Leveraging the power of artificial intelligence and Philips' cloud-based HealthSuite Digital Platform, IntelliSpace Cognition provides healthcare professionals with a powerful aid for assessing cognitive impairment. IntelliSpace Cognition automates and enhances well-established neuropsychological tests, offering new insights for clinicians treating patients with debilitating neurological conditions. It provides direct access to detailed information about a patient's cognition while also providing quantitative longitudinal data to aid in assessing disease progression and treatment efficacy.